Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 Vaccine May 25, 2021 Press Releases
Oramed Pharmaceuticals and Oravax Medical to be Featured in Alliance Global Partners’ Grand Rounds: A Webinar in Biotech and Specialty Pharma April 21, 2021 Press Releases
Oramed Initiates Second Phase 3 Oral Insulin Study Under the FDA’s Approved Dual Concurrent Protocol March 23, 2021 Press Releases
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines March 19, 2021 Press Releases
Oramed Reaches 25% Randomization in World’s First Phase 3 Oral Insulin Study Conducted Under FDA Approved Protocol March 16, 2021 Press Releases
Oramed to Present at H.C. Wainwright Global Life Sciences Conference 2021 March 4, 2021 Press Releases
Oramed Doses Patients Across Multiple Sites in Phase 3 Oral Insulin Study January 21, 2021 Press Releases
